Halozyme Therapeutics shares owned by Granite Investment Partners
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Granite Investment Partners
from 13F filings
Historical chart of Granite Investment Partners investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Granite Investment Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Granite Investment Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.2M | 29k | 73.34 |
| 2025-06-30 | $4.5M | 87k | 52.02 |
| 2025-03-31 | $8.3M | 130k | 63.81 |
| 2024-12-31 | $20M | 409k | 47.81 |
| 2024-09-30 | $25M | 439k | 57.24 |
| 2024-06-30 | $39M | 753k | 52.36 |
| 2024-03-31 | $33M | 812k | 40.68 |
| 2023-09-30 | $33M | 856k | 38.20 |
| 2023-06-30 | $27M | 758k | 36.07 |
| 2023-03-31 | $27M | 715k | 38.19 |
| 2022-12-31 | $51M | 903k | 56.90 |
| 2022-09-30 | $36M | 920k | 39.54 |
| 2022-06-30 | $41M | 934k | 44.00 |
| 2022-03-31 | $37M | 924k | 39.88 |
| 2021-12-31 | $38M | 935k | 40.21 |
| 2021-09-30 | $36M | 890k | 40.68 |
| 2021-06-30 | $42M | 919k | 45.41 |
| 2021-03-31 | $38M | 916k | 41.69 |
| 2020-12-31 | $40M | 944k | 42.71 |
| 2020-09-30 | $35M | 1.3M | 26.28 |
| 2020-06-30 | $34M | 1.3M | 26.81 |
| 2020-03-31 | $23M | 1.3M | 17.99 |
| 2019-12-31 | $23M | 1.3M | 17.73 |
| 2019-09-30 | $14M | 867k | 15.51 |
| 2019-06-30 | $15M | 857k | 17.18 |
| 2019-03-31 | $16M | 1.0M | 16.10 |
| 2018-12-31 | $15M | 989k | 14.63 |
| 2018-09-30 | $14M | 765k | 18.17 |
| 2018-06-30 | $12M | 735k | 16.87 |
| 2018-03-31 | $14M | 732k | 19.59 |
| 2017-12-31 | $15M | 749k | 20.26 |
| 2017-09-30 | $14M | 819k | 17.37 |
| 2017-06-30 | $7.2M | 566k | 12.82 |
More positions owned by Granite Investment Partners
View all positions for Granite Investment Partners